- Investing Ideas
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Daiichi Sankyo Company
Market Cap: JP¥5.2t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,818.50
7D
-1.7%
1Y
-19.5%
Chugai Pharmaceutical
Market Cap: JP¥15.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥9,362.00
7D
-2.3%
1Y
36.1%
Takeda Pharmaceutical
Market Cap: JP¥9.0t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥5,673.00
7D
-0.2%
1Y
28.0%